Alessandra Villa

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Pulmonary Hypertension

Renal Cell Carcinoma

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

International journal of molecular sciences

Philochem (Switzerland)

ETH-Zurich (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Philochem (Switzerland) Jan 01 2018

Switzerland

Group Leader :: Antibody Engineering Group

Philochem (Switzerland) Feb 01 2016 - Dec 31 2017

Switzerland

Senior Scientist :: Antibody Engineering Group

Istituto Europeo di Oncologia Jun 01 2011 - Jan 31 2016

Italy

Post Doc :: Gynecologic oncology

Philochem (Switzerland) Oct 09 2008 - May 31 2011

Switzerland

Lab Head :: Antibody Engineering group

Education History

ETH-Zurich Jan 09 2006 - Oct 08 2008

Switzerland

PHD :: D-CHAB

Universita degli Studi di Milano-Bicocca Sep 01 2000 - Nov 03 2005

Italy

MSC :: Biotecnology and Biosciences

Publications

Louis Plüss, Frederik Peissert, Abdullah Elsayed, Giulia Rotta, Jonas Römer, Sheila Dakhel, Alessandra Villa, Emanuele Puca, Roberto De Luca, Annette Oxenius, Dario Neri
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen. mAbs 15 (1) (2023)
Lisa Nadal, Riccardo Corbellari, Alessandra Villa, Tobias Weiss, Michael Weller, Dario Neri, Roberto De Luca
Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo. mAbs 12 (1) (2021)
Baptiste Gouyou, Katja Grün, Anne Kerschenmeyer, Alessandra Villa, Mattia Matasci, Andrea Schrepper, Alexander Pfeil, Laura Bäz, Christian Jung, P Christian Schulze, Dario Neri, Marcus Franz
Therapeutic Evaluation of Antibody-Based Targeted Delivery of Interleukin 9 in Experimental Pulmonary Hypertension. International journal of molecular sciences 22 (7) (2021)
Jacqueline Mock, Marco Stringhini, Alessandra Villa, Michael Weller, Tobias Weiss, Dario Neri
An engineered 4-1BBL fusion protein with "activity on demand". Proceedings of the National Academy of Sciences of the United States of America 117 (50) (2020)